🔗 Share this article

A shadow market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to users injecting substances of uncertain source.

Several experts stated the demand for the experimental drug could be connected to the increasing cost of licensed slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or prison.

Service Reaction and Material Removal

According to the social media company, the service has taken down violative material and prohibited related hashtags and query recommendations. The company stated it was committed to maintaining the service safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also found communities with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of members, filled with photos of slimming results, positive reviews and step-by-step guides for mixing or injecting at home.

Within moments of entering one community, a vendor posted contact information, where the majority of purchases occur. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Information and Costs

Inside these communities, posts display dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens usually priced at £160 for 20 milligrams. When asked how long a injector should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service stated it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they can’t verify. Although the research behind this drug is valid, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has previously seen patients injured by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to possibly serious health risks”.